Search research articles
Contact Us
Filters
Showing results (81-90 of 117) with videos related to
Page
of 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 12, 2010
Targeted gene silencing using RGD-labeled chitosan nanoparticles
Hee Dong Han, Lingegowda S Mangala, Jeong Won Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 15, 2010
EphA2 targeted chemotherapy using an antibody drug conjugate in endometrial carcinoma
Jeong-Won Lee, Rebecca L Stone, Sun Joo Lee, et al.
Molecular Cancer Therapeutics
|
April 24, 2014
Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer
Kshipra M Gharpure, Kevin S Chu, Charles J Bowerman, et al.
Cell Reports
|
March 12, 2014
Autocrine effects of tumor-derived complement
Min Soon Cho, Hernan G Vasquez, Rajesha Rupaimoole, et al.
Scientific Reports
|
March 19, 2020
Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer
E Sun Paik, Tae-Hyun Kim, Young Jae Cho, et al.
Drug Delivery
|
June 13, 2018
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer
Ga Hee Kim, Ji Eun Won, Yeongseon Byeon, et al.
Scientific Reports
|
December 3, 2016
In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy
Hee Dong Han, Yeongseon Byeon, Jong-Hwa Jang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2012
Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma
Sun Joo Lee, Sukhen C Ghosh, Hee Dong Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2011
Functional roles of Src and Fgr in ovarian carcinoma
Hye-Sun Kim, Hee Dong Han, Guillermo N Armaiz-Pena, et al.
Journal of the National Cancer Institute
|
July 31, 2009
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma
Jeong-Won Lee, Hee Dong Han, Mian M K Shahzad, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 117) with videos related to
Sort By:
Page
of 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 12, 2010
Targeted gene silencing using RGD-labeled chitosan nanoparticles
Hee Dong Han, Lingegowda S Mangala, Jeong Won Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 15, 2010
EphA2 targeted chemotherapy using an antibody drug conjugate in endometrial carcinoma
Jeong-Won Lee, Rebecca L Stone, Sun Joo Lee, et al.
Molecular Cancer Therapeutics
|
April 24, 2014
Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer
Kshipra M Gharpure, Kevin S Chu, Charles J Bowerman, et al.
Cell Reports
|
March 12, 2014
Autocrine effects of tumor-derived complement
Min Soon Cho, Hernan G Vasquez, Rajesha Rupaimoole, et al.
Scientific Reports
|
March 19, 2020
Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer
E Sun Paik, Tae-Hyun Kim, Young Jae Cho, et al.
Drug Delivery
|
June 13, 2018
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer
Ga Hee Kim, Ji Eun Won, Yeongseon Byeon, et al.
Scientific Reports
|
December 3, 2016
In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy
Hee Dong Han, Yeongseon Byeon, Jong-Hwa Jang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2012
Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma
Sun Joo Lee, Sukhen C Ghosh, Hee Dong Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2011
Functional roles of Src and Fgr in ovarian carcinoma
Hye-Sun Kim, Hee Dong Han, Guillermo N Armaiz-Pena, et al.
Journal of the National Cancer Institute
|
July 31, 2009
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma
Jeong-Won Lee, Hee Dong Han, Mian M K Shahzad, et al.
Page
of 12